Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: shasta23 who wrote (11641)	11/24/1997 1:49:00 PM
From: Andrew H	Respond to of 32384

>>is there any rational explanation why nov/dec is good for biotechs in general. we don't see that up to here so i'd like to know if that's also true for weak markets?<< There are a large number of biotech conferences in the fall, culminating in the H and Q conference in January. Some bios announce their good news at these conferences and everyone gets to hear what's going on in the industry. However, simultaneously there is considerable tax selling in Oct, Nov, and the earlier part of December. Then there is the year end rally and the January effect for small caps. So the seasonal trend combines with the year end rally and the January effect. Of course one cannot count on such a biotech rally, altho it has established a strong pattern, and in the current nervous market, companies without earnings are more vulnerable than others.